Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
AssigneeSmithKline Beecham Corporation
InventorsJacques Dubois, Claude St-Pierre
Life of this patent
Estimating the term…
Abstract
This invention relates, in part, to newly identified methods of using quinolone antibiotics, particularly a gemifloxacin compound against atypical upper respiratory pathogenic bacteria
Claims16
A method for modulating metabolism of atypical upper respiratory pathogenic bacteria comprising the step of contacting atypical upper respiratory pathogenic bacteria with an antibacterially effective amount of a composition comprising a gemifloxacin compound, or antibacterially effective derivatives thereof.
A method of treating or preventing a bacterial infection by atypical upper respiratory pathogenic bacteria comprising the step of administering an antibacterially effective amount of a composition comprising a gemifloxacin compound to a mammal suspected of having or being at risk of having an infection with atypical upper respiratory pathogenic bacteria.
A method for modulating metabolism of atypical upper respiratory pathogenic bacteria comprising the step of contacting atypical upper respiratory pathogenic bacteria with an antibacterially effective amount of a composition comprising a compound selected from the group consisting of:
- gemifloxacin, ofloxacin, levofloxacin, trovafloxacin, azithromycin, moxifloxacin, ciprofloxacin, clarithromycin, rifampicin and erythromycin;
- or an antibacterially effective derivative of any of these compounds.
A method of treating or preventing a bacterial infection by atypical upper respiratory pathogenic bacteria comprising the step of administering an antibacterially effective amount of a composition comprising a compound selected from the group consisting of:
- gemifloxacin, ofloxacin, levofloxacin, trovafloxacin, azithromycin, moxifloxacin, ciprofloxacin, clarithromycin, rifampicin and erythromycin;
- or an antibacterially effective derivative of any of these compounds,
- to a mammal suspected of having or being at risk of having an infection with atypical upper respiratory pathogenic bacteria.
Dependencies are inferred from the claim text.